96 related articles for article (PubMed ID: 22960196)
1. In vivo effect of glucose-dependent insulinotropic peptide (GIP) on the gene expression of calcitonin peptides in human subcutaneous adipose tissue.
Pivovarova O; Gögebakan O; Osterhoff MA; Nauck M; Pfeiffer AF; Rudovich N
Regul Pept; 2012 Nov; 179(1-3):29-32. PubMed ID: 22960196
[TBL] [Abstract][Full Text] [Related]
2. Glucose-dependent insulinotropic polypeptide (GIP) induces calcitonin gene-related peptide (CGRP)-I and procalcitonin (Pro-CT) production in human adipocytes.
Timper K; Grisouard J; Radimerski T; Dembinski K; Peterli R; Häring A; Frey DM; Zulewski H; Keller U; Müller B; Christ-Crain M
J Clin Endocrinol Metab; 2011 Feb; 96(2):E297-303. PubMed ID: 21106708
[TBL] [Abstract][Full Text] [Related]
3. GIP increases adipose tissue expression and blood levels of MCP-1 in humans and links high energy diets to inflammation: a randomised trial.
Gögebakan Ö; Osterhoff MA; Schüler R; Pivovarova O; Kruse M; Seltmann AC; Mosig AS; Rudovich N; Nauck M; Pfeiffer AF
Diabetologia; 2015 Aug; 58(8):1759-68. PubMed ID: 25994074
[TBL] [Abstract][Full Text] [Related]
4. Glucose-dependent insulinotropic polypeptide promotes lipid deposition in subcutaneous adipocytes in obese type 2 diabetes patients: a maladaptive response.
Thondam SK; Daousi C; Wilding JP; Holst JJ; Ameen GI; Yang C; Whitmore C; Mora S; Cuthbertson DJ
Am J Physiol Endocrinol Metab; 2017 Mar; 312(3):E224-E233. PubMed ID: 28073779
[TBL] [Abstract][Full Text] [Related]
5. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W
J Clin Endocrinol Metab; 1993 Apr; 76(4):912-7. PubMed ID: 8473405
[TBL] [Abstract][Full Text] [Related]
6. Metabolomic linkage reveals functional interaction between glucose-dependent insulinotropic polypeptide and ghrelin in humans.
Rudovich NN; Nikiforova VJ; Otto B; Pivovarova O; Gögebakan O; Erban A; Möhlig M; Weickert MO; Spranger J; Tschöp MH; Willmitzer L; Nauck M; Pfeiffer AF
Am J Physiol Endocrinol Metab; 2011 Oct; 301(4):E608-17. PubMed ID: 21586700
[TBL] [Abstract][Full Text] [Related]
7. Insulin Plays a Permissive Role for the Vasoactive Effect of GIP Regulating Adipose Tissue Metabolism in Humans.
Asmar M; Simonsen L; Asmar A; Holst JJ; Dela F; Bülow J
J Clin Endocrinol Metab; 2016 Aug; 101(8):3155-62. PubMed ID: 27258938
[TBL] [Abstract][Full Text] [Related]
8. Glucose-dependent insulinotropic polypeptide has impaired effect on abdominal, subcutaneous adipose tissue metabolism in obese subjects.
Asmar M; Simonsen L; Arngrim N; Holst JJ; Dela F; Bülow J
Int J Obes (Lond); 2014 Feb; 38(2):259-65. PubMed ID: 23736366
[TBL] [Abstract][Full Text] [Related]
9. The effect of age and glycemic level on the response of the beta-cell to glucose-dependent insulinotropic polypeptide and peripheral tissue sensitivity to endogenously released insulin.
Meneilly GS; Ryan AS; Minaker KL; Elahi D
J Clin Endocrinol Metab; 1998 Aug; 83(8):2925-32. PubMed ID: 9709971
[TBL] [Abstract][Full Text] [Related]
10. The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.
Vilsbøll T; Knop FK; Krarup T; Johansen A; Madsbad S; Larsen S; Hansen T; Pedersen O; Holst JJ
J Clin Endocrinol Metab; 2003 Oct; 88(10):4897-903. PubMed ID: 14557471
[TBL] [Abstract][Full Text] [Related]
11. Disruption of GIP/GIPR axis in human adipose tissue is linked to obesity and insulin resistance.
Ceperuelo-Mallafré V; Duran X; Pachón G; Roche K; Garrido-Sánchez L; Vilarrasa N; Tinahones FJ; Vicente V; Pujol J; Vendrell J; Fernández-Veledo S
J Clin Endocrinol Metab; 2014 May; 99(5):E908-19. PubMed ID: 24512489
[TBL] [Abstract][Full Text] [Related]
12. The blunted effect of glucose-dependent insulinotropic polypeptide in subcutaneous abdominal adipose tissue in obese subjects is partly reversed by weight loss.
Asmar M; Arngrim N; Simonsen L; Asmar A; Nordby P; Holst JJ; Bülow J
Nutr Diabetes; 2016 May; 6(5):e208. PubMed ID: 27136446
[TBL] [Abstract][Full Text] [Related]
13. Insulinotropic properties of synthetic human gastric inhibitory polypeptide in man: interactions with glucose, phenylalanine, and cholecystokinin-8.
Nauck M; Schmidt WE; Ebert R; Strietzel J; Cantor P; Hoffmann G; Creutzfeldt W
J Clin Endocrinol Metab; 1989 Sep; 69(3):654-62. PubMed ID: 2668324
[TBL] [Abstract][Full Text] [Related]
14. Glucose-dependent insulinotropic polypeptide may enhance fatty acid re-esterification in subcutaneous abdominal adipose tissue in lean humans.
Asmar M; Simonsen L; Madsbad S; Stallknecht B; Holst JJ; Bülow J
Diabetes; 2010 Sep; 59(9):2160-3. PubMed ID: 20547981
[TBL] [Abstract][Full Text] [Related]
15. Glucose-dependent insulinotropic polypeptide inhibits bone resorption in humans.
Nissen A; Christensen M; Knop FK; Vilsbøll T; Holst JJ; Hartmann B
J Clin Endocrinol Metab; 2014 Nov; 99(11):E2325-9. PubMed ID: 25144635
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of insulin secretory response to glucose-dependent insulinotropic polypeptide (GIP) by growth hormone in dogs.
Pierluissi J; de Pierluissi R; de Martínez A
Acta Cient Venez; 2002; 53(1):29-35. PubMed ID: 12216497
[TBL] [Abstract][Full Text] [Related]
17. Effects of endogenous GIP in patients with type 2 diabetes.
Stensen S; Gasbjerg LS; Krogh LL; Skov-Jeppesen K; Sparre-Ulrich AH; Jensen MH; Dela F; Hartmann B; Vilsbøll T; Holst JJ; Rosenkilde MM; Christensen MB; Knop FK
Eur J Endocrinol; 2021 May; 185(1):33-45. PubMed ID: 33886495
[TBL] [Abstract][Full Text] [Related]
18. The Gluco- and Liporegulatory and Vasodilatory Effects of Glucose-Dependent Insulinotropic Polypeptide (GIP) Are Abolished by an Antagonist of the Human GIP Receptor.
Asmar M; Asmar A; Simonsen L; Gasbjerg LS; Sparre-Ulrich AH; Rosenkilde MM; Hartmann B; Dela F; Holst JJ; Bülow J
Diabetes; 2017 Sep; 66(9):2363-2371. PubMed ID: 28667118
[TBL] [Abstract][Full Text] [Related]
19. Increased GIP signaling induces adipose inflammation via a HIF-1α-dependent pathway and impairs insulin sensitivity in mice.
Chen S; Okahara F; Osaki N; Shimotoyodome A
Am J Physiol Endocrinol Metab; 2015 Mar; 308(5):E414-25. PubMed ID: 25537494
[TBL] [Abstract][Full Text] [Related]
20. Glucose-dependent insulinotropic polypeptide induces cytokine expression, lipolysis, and insulin resistance in human adipocytes.
Timper K; Grisouard J; Sauter NS; Herzog-Radimerski T; Dembinski K; Peterli R; Frey DM; Zulewski H; Keller U; Müller B; Christ-Crain M
Am J Physiol Endocrinol Metab; 2013 Jan; 304(1):E1-13. PubMed ID: 23092914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
